PCYT1A suppresses proliferation and migration via inhibiting mTORC1 pathway in lung adenocarcinoma

Jing Yu1, Changtao Wu2, Qi Wu3

  • 1Department of Oncology, The Affiliated Hospital of Southwest Medical University, Luzhou, 646000, China; Institute of Pathology and Southwest Cancer Center, Southwest Hospital, Third Military Medical University (Army Medical University), And Key Laboratory of Tumor Immunopathology, Ministry of Education of China, Chongqing, China.

Insights

Phosphatidylcholine biosynthesis enzyme PCYT1A suppresses lung adenocarcinoma cell growth and migration by inhibiting mTORC1 signaling. High PCYT1A expression correlates with better lung cancer patient survival, indicating its potential as a biomarker.

Area of Science:

  • Oncology
  • Molecular Biology
  • Biochemistry

Background:

  • Lung adenocarcinoma is a prevalent malignancy with complex progression mechanisms.
  • The role of PCYT1A (cytidine triphosphate:phosphocholine cytidylyltransferase) in lung adenocarcinoma remains largely uncharacterized.
  • PCYT1A is a key enzyme in phosphatidylcholine biosynthesis, essential for cell membrane integrity and signaling.

Purpose of the Study:

  • To elucidate the biological functions and molecular mechanisms of PCYT1A in lung adenocarcinoma.
  • To investigate the relationship between PCYT1A expression and cancer cell behavior.
  • To determine the potential of PCYT1A as a prognostic biomarker in lung cancer.

Main Methods:

  • Cell proliferation and migration assays were performed.
  • Western blotting was used to assess protein levels and signaling pathway activation.
  • The effect of PCYT1A modulation on mTORC1 signaling was examined.
  • Correlation analysis was conducted between PCYT1A expression and clinical outcomes in lung cancer patients.

Main Results:

  • PCYT1A suppressed lung adenocarcinoma cell proliferation and migration.
  • PCYT1A acted as a negative regulator of mTORC1 signaling.
  • PCYT1A knockdown enhanced cell proliferation and migration via mTORC1 activation.
  • Inhibition of mTORC1 signaling abolished the promoting effects of PCYT1A silencing.
  • High PCYT1A expression was associated with longer survival in lung cancer patients.
  • PCYT1A expression inversely correlated with mTORC1 activation in clinical samples.

Conclusions:

  • PCYT1A inhibits lung adenocarcinoma cell proliferation and migration by suppressing the mTORC1 signaling pathway.
  • PCYT1A functions as a tumor suppressor in lung adenocarcinoma.
  • PCYT1A is a potential prognostic biomarker for lung adenocarcinoma, with high expression indicating a favorable outcome.

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.5K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.0K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
5.0K
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
5.4K
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
7.0K
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
4.5K